Sexual health and rehabilitation after ovarian suppression treatment (SHARE-OS): a clinical intervention for young breast cancer survivors

Bober, Sharon L.; Fine, Elizabeth; Recklitis, Christopher J.

doi:10.1007/s11764-019-00800-x

Cited by 33 publications

(19 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Likewise, several studies reported patients expected sexual health care and discussion but clinicians mostly prefer to pay more attention to combat the disease due to the lack of adequate knowledge and busy clinics [39]. Sexual function has improved in breast cancer survivors with a one-time nursing intervention for African American survivors in a six-session couples sex therapy program [40]. Patientsclinicians communication regarding sexual health is critical and necessary routine assessment in breast cancer survivors with ovarian function suppression during treatment planning and at follow-up, independent of the type of ovarian suppression.…”

Section: Discussionmentioning

confidence: 99%

Depression, Sexual dysfunction and Quality of Life Among Breast Cancer Patients with Ovarian Function Suppression: A Cross Sectional Study between Ovarian Ablation Verse GnRH Agonists

Jiang

Cai

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: Ovarian function suppression is being widely utilized as endocrine therapy to reduce estrogen release in premenopausal breast cancer patients and was achieved either by medical treatment with bilateral oophorectomy, irradiation, or the Gonadotropin releasing hormone (GnRH) agonist. This study aimed to examine whether GnRHa differed from ovarian ablation on depression, sexual dysfunction and quality of life.Methods: The premenopausal breast cancer patients who received ovarian function suppression were enrolled from seven hospital between June 2019 and June 2020. Our independent variable was the type of ovarian suppression, categorized as Ovarian Ablation (OA cohort, n=174) and medical GnRH agonist (GnRHa cohort, n=389). The self-administered questionnaire (OFS-Q5) was developed and used in this study aimed to assess the depression (PHQ-9), sexual dysfunction (FSFI) and quality of life (EORTC QLQ-BR23).Results: In this cross-sectional study, 563 patients with ovarian function suppression completed surveys were collected. The mean sum score of the PHQ-9 tend to be slight decrease in GnRHa cohort than that in ovarian ablation (OA) cohort (11.4 ±5.7 vs. 12.8 ±5.8, OR=1.910, P=0.079). Patients with major depression (PHQ-9≧15) was indicated significantly fewer in GnRHa cohort (31.1% vs 40.2%, P=0.025). The more surprising correlation is less patients with sexual dysfunction (61.5%, FSFI< 23) in OA cohort, a remarkable increase in GnRHa cohort (72.2%, P = 0.011). The ratio of sexual dysfunction remained lower for ovarian ablation women in long-term ovarian suppression (duration of ovarian suppression > 2 years: OA vs GnRHa, OR=1.555, P=0.037). No significantly difference for most subscales of QLQ-BR23 between two cohorts was evident.Conclusions: Our current investigation demonstrate here for the first time that medical GnRHa resulted in favour depression, worse sexual function than those with ovarian ablation, with similar quality of life. This new understanding should help to improve and alleviate adverse effect in patients with diverse ovarian function suppression.

show abstract

Section: Discussionmentioning

confidence: 99%

Depression, Sexual dysfunction and Quality of Life Among Breast Cancer Patients with Ovarian Function Suppression: A Cross Sectional Study between Ovarian Ablation Verse GnRH Agonists

Jiang

Cai

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…Overall, 1365 patients were included, most of which had breast cancer (a small number of patients had a different form of cancer), and the sample size range was 20-245. The main form of instruction was group coaching (11 trials) [31][32][33][34][35][36][37][38][39][40][41]. Participants in 2 studies attended personalized MBCT sessions led by an experienced therapist [42,43].…”

Section: Study Descriptions and Quality Assessmentsmentioning

confidence: 99%

Immediate Impact of Mindfulness-Based Cognitive Therapy on Women with Breast Cancer: A Systematic Review and Meta‐analysis

Chang¹,

Chang

2022

Preprint

View full text Add to dashboard Cite

Background Mindfulness-based cognitive therapy (MBCT) may have positive physiological and psychological benefits for patients with breast cancer, in addition to enhancing their quality of life. However, few studies have involved synthesis of the relevant literature to confirm these effects. This meta-analysis examined the associations between MBCT and various symptoms after Western medicine–based drug treatment. Methods This study considered randomized controlled trials (RCTs) as well as non-RCTs comparing MBCT interventions and control protocols for the alleviation of symptoms among women with breast cancer. We calculated pooled mean differences (MDs), standardized mean differences (SMDs), and 95% confidence intervals (CIs) by using random effects models to estimate summary effect sizes. Results Thirteen RCTs and non-RCTs with 20–245 participants were considered in our systematic review; for our meta-analysis, 11 of these studies were eligible for assessment. The pooled meta-analysis results revealed that at the end of the MBCT intervention, participants’ anxiety (SMD, − 0.70; 95% CI, − 1.26 to − 0.13; I2 = 69%), pain (SMD, − 0.64; 95% CI, − 0.92 to − 0.37; I2 = 0%), and depression (SMD, − 0.65; 95% CI, − 1.14 to − 0.17; I2 = 75%) levels had significantly decreased, and their mindfulness (MD, 8.83; 95% CI, 3.88 to 13.78; I2 = 68%) levels significantly increased. Conclusion Our results suggest that MBCT is highly beneficial and cost-effective as an intervention for patients who have received treatment for breast cancer.

show abstract

“…Literature (Schneider et al, 2017) uses principal component analysis to improve CCA to ensure accuracy and improve the speed of signal recognition at the same time. Previous work (Bober et al, 2020) uses a wavelet packet to improve CCA as shown in Figure 4, which improves accuracy by about 5% and gets 82% accuracy. In the literature, a power spectrum Gaussian method based on empirical mode decomposition is proposed to achieve 84% accuracy.…”

Section: Research On Visual Driving Potential Systemmentioning

confidence: 99%

Rehabilitation Treatment of Motor Dysfunction Patients Based on Deep Learning Brain–Computer Interface Technology

Wang

Yan

et al. 2020

Front. Neurosci.

View full text Add to dashboard Cite

In recent years, brain-computer interface (BCI) is expected to solve the physiological and psychological needs of patients with motor dysfunction with great individual differences. However, the classification method based on feature extraction requires a lot of prior knowledge when extracting data features and lacks a good measurement standard, which makes the development of BCI. In particular, the development of a multiclassification brain-computer interface is facing a bottleneck. To avoid the blindness and complexity of electroencephalogram (EEG) feature extraction, the deep learning method is applied to the automatic feature extraction of EEG signals. It is necessary to design a classification model with strong robustness and high accuracy for EEG signals. Based on the research and implementation of a BCI system based on a convolutional neural network, this article aims to design a brain-computer interface system that can automatically extract features of EEG signals and classify EEG signals accurately. It can avoid the blindness and time-consuming problems caused by the machine learning method based on feature extraction of EEG data due to the lack of a large amount of prior knowledge.

show abstract

Sexual health and rehabilitation after ovarian suppression treatment (SHARE-OS): a clinical intervention for young breast cancer survivors

Cited by 33 publications

References 10 publications

Depression, Sexual dysfunction and Quality of Life Among Breast Cancer Patients with Ovarian Function Suppression: A Cross Sectional Study between Ovarian Ablation Verse GnRH Agonists

Depression, Sexual dysfunction and Quality of Life Among Breast Cancer Patients with Ovarian Function Suppression: A Cross Sectional Study between Ovarian Ablation Verse GnRH Agonists

Immediate Impact of Mindfulness-Based Cognitive Therapy on Women with Breast Cancer: A Systematic Review and Meta‐analysis

Rehabilitation Treatment of Motor Dysfunction Patients Based on Deep Learning Brain–Computer Interface Technology

Contact Info

Product

Resources

About